SGLT2 inhibitors but not other antidiabetic drugs improve frailty in older adults with diabetes and HFpEF.

Mone, Pasquale, Marco Ferrone, Francesco Spione, Dimitris Christodoulakis, Francesco Melillo, Antonio Rainone, Domenico Ponticelli, et al. “SGLT2 Inhibitors But Not Other Antidiabetic Drugs Improve Frailty in Older Adults With Diabetes and HFpEF.”. Cardiovascular Research, 2026.
Last updated on 03/24/2026
PubMed